Comparison of ABC transporter modulation by atazanavir in lymphocytes and human brain endothelial cells: ABC transporters are involved in the atazanavir-limited passage across an in vitro human model of the blood-brain barrier

AIDS Research and Human Retroviruses
Laurence BousquetAloïse Mabondzo

Abstract

Efflux pumps, P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP) have been shown to extrude HIV protease inhibitors from cells. These transporters are present on many barrier sites such as the blood-brain barrier (BBB) and on many circulating cells such as lymphocytes, and could reduce protease inhibitor concentration in sanctuary or HIV-1 target sites. This study compares the potential of the antiretroviral drug atazanavir to modulate P-gp and MRP expression and function in total lymphocytes and in human fetal brain endothelial cells (HBMECs). We address the question of atazanavir transport across the human BBB. Following incubation with atazanavir, P-gp and MRP1 expression was determined by direct immunofluorescence. Transporter function was assessed by measuring fluorescent dye efflux, either with or without specific inhibitors. Atazanavir substrate properties were determined by transport quantification through a validated in vitro human BBB model. Our results show that in contrast to HBMECs, in lymphocytes, atazanavir has no effect on MRP1 and P-gp expression. However, there were overall changes in P-gp function increasing its activity in lymphocytes and HBMEC...Continue Reading

References

Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Dec 12, 1985·The New England Journal of Medicine·P H Black
Mar 8, 1995·Biochemical and Biophysical Research Communications·V GekelerJ Beck
Feb 7, 1998·The Journal of Clinical Investigation·R B KimG R Wilkinson
Mar 30, 2000·International Journal of Clinical Pharmacology and Therapeutics·A SeeligF Wohnsland
Aug 11, 2001·Cellular and Molecular Life Sciences : CMLS·T LitmanS E Bates
Nov 2, 2001·Biochemical and Biophysical Research Communications·C FernettiC Tiribelli
Aug 9, 2003·Drugs·David R Goldsmith, Caroline M Perry
Aug 15, 2003·The Journal of Antimicrobial Chemotherapy·J FordD J Back
Mar 10, 2004·The Journal of Pharmacology and Experimental Therapeutics·Anshul GuptaQingcheng Mao
May 25, 2004·Antimicrobial Agents and Chemotherapy·Anne-Marie TaburetPierre-Marie Girard
Mar 15, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Elke S PerloffLisa L von Moltke
Jan 5, 2006·Cerebrospinal Fluid Research·Christy AnthonypillaiSarah A Thomas
Feb 4, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jarkko RautioJoseph W Polli
Jan 5, 2007·The Journal of Antimicrobial Chemotherapy·Johanna WeissThomas Efferth
Mar 3, 2007·Biochemical Pharmacology·Caroline Henrike StorchJohanna Weiss
May 19, 2007·The Journal of Antimicrobial Chemotherapy·Leslie W ChinnDeanna L Kroetz
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Michael D PerloffDavid J Greenblatt
Oct 18, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gérard SiestSophie Visvikis-Siest

❮ Previous
Next ❯

Citations

Mar 8, 2012·AIDS Research and Human Retroviruses·Deidre A KilePeter L Anderson
Jul 4, 2009·Nanomedicine·Ari Nowacek, Howard E Gendelman
Jan 15, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Adrienne C MüllerIsadore Kanfer
Apr 7, 2010·Expert Opinion on Drug Metabolism & Toxicology·Carole GiraudJean-Marc Treluyer
Jun 24, 2011·Journal of Pharmaceutical Sciences·Latoya GriffinKim L R Brouwer
Sep 15, 2015·AIDS Research and Human Retroviruses·Yancong ZhouYonggang Ma
Aug 12, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Laurence BousquetAloïse Mabondzo
Sep 23, 2014·Chemistry & Biology·Bradley Croy DoakJan Kihlberg
Apr 15, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Mark BerlinJennifer B Dressman
Dec 17, 2009·Trends in Pharmacological Sciences·Olena KisReina Bendayan
Oct 22, 2014·Clinical Pharmacokinetics·Victoria TittleNneka Nwokolo
Apr 14, 2016·Advanced Drug Delivery Reviews·Pär MatssonJan Kihlberg
May 18, 2016·Advanced Drug Delivery Reviews·Camille AlamReina Bendayan
Oct 26, 2016·AIDS Research and Treatment·Jacinta Nwamaka NwoguBabafemi Taiwo
Jan 12, 2019·Journal of Psychiatric Practice·Sheldon H Preskorn
Feb 25, 2018·The Journal of Pharmacology and Experimental Therapeutics·JoEllyn M McMillanLarisa Y Poluektova
May 30, 2019·The AAPS Journal·Jean-Marie Nicolas, Elizabeth C M de Lange
May 4, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Devendra Kumar, Neerja Trivedi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Related Papers

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Elke S PerloffLisa L von Moltke
The Journal of Antimicrobial Chemotherapy
Johanna WeissThomas Efferth
© 2022 Meta ULC. All rights reserved